166 research outputs found

    Origins of plateau formation in ion energy spectra under target normal sheath acceleration

    Full text link
    Target normal sheath acceleration (TNSA) is a method employed in laser--matter interaction experiments to accelerate light ions (usually protons). Laser setups with durations of a few 10 fs and relatively low intensity contrasts observe plateau regions in their ion energy spectra when shooting on thin foil targets with thicknesses of order 10 Ό\mathrm{\mu}m. In this paper we identify a mechanism which explains this phenomenon using one dimensional particle-in-cell simulations. Fast electrons generated from the laser interaction recirculate back and forth through the target, giving rise to time-oscillating charge and current densities at the target backside. Periodic decreases in the electron density lead to transient disruptions of the TNSA sheath field: peaks in the ion spectra form as a result, which are then spread in energy from a modified potential driven by further electron recirculation. The ratio between the laser pulse duration and the recirculation period (dependent on the target thickness, including the portion of the pre-plasma which is denser than the critical density) determines if a plateau forms in the energy spectra.Comment: 11 pages, 12 figure

    High-energy acceleration phenomena in extreme radiation-plasma interactions

    Full text link
    We simulate, using a particle-in-cell code, the chain of acceleration processes at work during the Compton-based interaction of a dilute electron-ion plasma with an extreme-intensity, incoherent gamma-ray flux with a photon density several orders of magnitude above the particle density. The plasma electrons are initially accelerated in the radiative flux direction through Compton scattering. In turn, the charge-separation field from the induced current drives forward the plasma ions to near-relativistic speed and accelerates backwards the non-scattered electrons to energies easily exceeding those of the driving photons. The dynamics of those energized electrons is determined by the interplay of electrostatic acceleration, bulk plasma motion, inverse Compton scattering and deflections off the mobile magnetic fluctuations generated by a Weibel-type instability. The latter Fermi-like effect notably gives rise to a forward-directed suprathermal electron tail. We provide simple analytical descriptions for most of those phenomena and examine numerically their sensitivity to the parameters of the problem

    Enhancement of laser-driven ion acceleration in non-periodic nanostructured targets

    Get PDF
    Using particle-in-cell simulations, we demonstrate an improvement of the target normal sheath acceleration (TNSA) of protons in non-periodically nanostructured targets with micron-scale thickness. Compared to standard flat foils, an increase in the proton cutoff energy by up to a factor of two is observed in foils coated with nanocones or perforated with nanoholes. The latter nano-perforated foils yield the highest enhancement, which we show to be robust over a broad range of foil thicknesses and hole diameters. The improvement of TNSA performance results from more efficient hot-electron generation, caused by a more complex laser-electron interaction geometry and increased effective interaction area and duration. We show that TNSA is optimized for a nanohole distribution of relatively low areal density and that is not required to be periodic, thus relaxing the manufacturing constraints.Comment: 11 pages, 8 figure

    Modeling target bulk heating resulting from ultra-intense short pulse laser irradiation of solid density targets

    Get PDF
    Isochoric heating of solid-density matter up to a few tens of eV is of interest for investigating astrophysical or inertial fusion scenarios. Such ultra-fast heating can be achieved via the energy deposition of short-pulse laser generated electrons. Here, we report on experimental measurements of this process by means of time-and space-resolved optical interferometry. Our results are found in reasonable agreement with a simple numerical model of fast electron-induced heating. (C) 2013 AIP Publishing LLC.</p

    Consistency of safety and efficacy of new oral anticoagulants across subgroups of patients with atrial fibrillation.

    Get PDF
    AIMS: The well-known limitations of vitamin K antagonists (VKA) led to development of new oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-analysis was to determine the consistency of treatment effects of NOAC irrespective of age, comorbidities, or prior VKA exposure. METHODS AND RESULTS: All randomized, controlled phase III trials comparing NOAC to VKA up to October 2012 were eligible provided their results (stroke/systemic embolism (SSE) and major bleeding (MB)) were reported according to age (≀ or &gt;75 years), renal function, CHADS2 score, presence of diabetes mellitus or heart failure, prior VKA use or previous cerebrovascular events. Interactions were considered significant at p &lt;0.05. Three studies (50,578 patients) were included, respectively evaluating apixaban, rivaroxaban, and dabigatran versus warfarin. A trend towards interaction with heart failure (p = 0.08) was observed with respect to SSE reduction, this being greater in patients not presenting heart failure (RR = 0.76 [0.67-0.86]) than in those with heart failure (RR = 0.90 [0.78-1.04]); Significant interaction (p = 0.01) with CHADS2 score was observed, NOAC achieving a greater reduction in bleeding risk in patients with a score of 0-1 (RR 0.67 CI 0.57-0.79) than in those with a score ≄2 (RR 0.85 CI 0.74-0.98). Comparison of MB in patients with (RR 0.97 CI 0.79-1.18) and without (RR 0.76 CI 0.65-0.88) diabetes mellitus showed a similar trend (p = 0.06). No other interactions were found. All subgroups derived benefit from NOA in terms of SSE or MB reduction. CONCLUSIONS: NOAC appeared to be more effective and safer than VKA in reducing SSE or MB irrespective of patient comorbidities. Thromboembolism risk, evaluated by CHADS2 score and, to a lesser extent, diabetes mellitus modified the treatment effects of NOAC without complete loss of benefit with respect to MB reduction
    • 

    corecore